https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/The-European-Commission-Grants-Marketing-Authorization-for-VUMERITY-diroximel-fumarate-as-Oral-Tr-37088895/?utm_source=telegram&utm_medium=social&utm_campaign=share